Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
Clinical trial NCT03549351 · TERMINATED
Trial details
- NCT number
- NCT03549351
- Sponsor
- University Hospital Heidelberg
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-01
- Primary completion
- 2022-09-11
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.